SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-066732
Filing Date
2024-05-30
Accepted
2024-05-30 17:11:25
Documents
9
Effectiveness Date
2024-05-30

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm243190d16_s8.htm S-8 65881
2 EXHIBIT 5.1 tm243190d16_ex5-1.htm EX-5.1 10009
3 EXHIBIT 10.1 tm243190d16_ex10-1.htm EX-10.1 148367
4 EXHIBIT 10.2 tm243190d16_ex10-2.htm EX-10.2 65196
5 EXHIBIT 10.3 tm243190d16_ex10-3.htm EX-10.3 60034
6 EXHIBIT 23.1 tm243190d16_ex23-1.htm EX-23.1 2303
7 EXHIBIT 23.2 tm243190d16_ex23-2.htm EX-23.2 3299
8 EX-FILING FEES tm243190d16_ex-filingfees.htm EX-FILING FEES 10884
9 GRAPHIC tm243190d16_ex5-1img001.jpg GRAPHIC 35164
  Complete submission text file 0001104659-24-066732.txt   415738
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Filer) CIK: 0002007919 (see all company filings)

IRS No.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279840 | Film No.: 241006529
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)